Hypertension in seven Latin American cities: The Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study

Journal of Hypertension

Volumn 28, Issue 1, 2010, Pages 24-34

  Hernández Hernández, Rafael ^a   Silva, Honorio ^b   Velasco, Manuel ^c   Pellegrini, Fabio ^d   MacChia, Alejandro ^e   Escobedo, Jorge ^f   Vinueza, Raul ^b   Schargrodsky, Herman ^g   Champagne, Beatriz ^h   Pramparo, Palmira ⁱ   Wilson, Elinor ^j  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b InterAmerican Foundation for Clinical Research   (United States)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^d Santa Maria Imbaro ^*  (Italy)

^e CSS Scientific Institute   (Italy)

^f INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^g HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^h InterAmerican Heart Foundation   (United States)

ⁱ InterAmerican Heart Foundation   (Argentina)

^j UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

more..

Author keywords

Blood pressure classification; Cardiovascular risk factors; Hypertension control; Hypertension prevalence; Total cardiovascular risk

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; SYSTOLIC BLOOD PRESSURE;

EID: 73849141494     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328332c353     Document Type: Article

References (33)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
2. Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
3. Arredondo A, Zúñiga A. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico. Am J Hypertens 2006; 19:553-559.
4. Ezzati M, Lopez A, Rodgers A, Vander Hoorn S, Murray C, and the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360:1347-1360.
5. Williams B. Recent hypertension trials: implications and controversies. J Am Coll Cardiol 2005; 45:813-827.
6. Periago MR, Lenfant C. Astandard method for measuring blood pressure in the Americas. Rev Panam Salud Publica 2003; 14:297. (Pubitemid 38056797)
7. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S, and INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 2007; 115:1067-1074. (Pubitemid 46673168)
8. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-952.
9. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006; 119:133-141.
10. Hernandez-Hernandez R, Armas-Padilla MC, Armas-Hernandez MJ, Velasco M. Hypertension and cardiovascular health in Venezuela and Latin American countries. J Hum Hypertens 2000; 14 (Suppl 1):S2-S5.
11. Schargrodsky H, Hernandez-Hernandez R,Champagne B, Silva H, Vinueza R, Silva Ayçaguer LC, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008; 121:58-65.
12. D́iaz ME. Hypertension and obesity. J Hum Hypertens 2002; 16 (Suppl 1): S18-S22.
13. de Sereday M, Gonzalez C, Giorgini D, De Loredo L, Braguinsky J, Cobeñas C, et al. Prevalence of diabetes, obesity, hypertension and hyperlipidemia in the central area of Argentina. Diabetes Metab 2004; 30:335-339.
14. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gonzalez-Villalpando C, et al. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 2002; 39:203-208.
15. Muntner P, He J, Roccella EJ, Whelton PK. The impact of JNC-VI guidelines on treatment recommendations in the US population. Hypertension 2002; 39:897-902.
16. Fasce E, Campos I, Ibánez P, Flores M, Zárate H, Román O, Fasce F. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens 2007; 25:1807-1811.
17. Hernandez-Hernandez R, Chacon-Ramirez R, Hernandez-Faraco A, Aguero RE, Hernández-Faraco G, Armas-Hernandez MJ, et al. Study of the incidence of arterial hypertension in Barquisimeto, Venezuela. Bol Med Postgrado 1994; 10:223-233.
18. Velazquez Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelin Hernandez G, Attie F, Tapia Conyer R. Arterial hypertension in Mexico: results of the National Health Survey 2000. Arch Cardiol Mex 2002; 72:71-84.
19. Rodŕiguez Saldaña J, Chávez Domínguez R, Marmolejo Henderson R, Reynoso Marenco M. Epidemiology of arterial hypertension in Mexico. Historical aspects. Med Interna Mex 1997; 13:283-288.
20. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49:69-75.
21. Ciruzzi M, Pramparo P, Rozlosnik J, Zylberstjn H, Delmonte H, Haquim M, et al. Hypertension and the risk of acute myocardial infarction in Argentina. The Argentine Factores de Riesgo Coronario en America del Sur (FRICAS) Investigators. Prev Cardiol 2001; 4:57-64.
22. Most Recent National Survey(s) for Chronic, Noncommunicable Disease Risk Factors. WHO Global InfoBase Web site. http://www.who.int/ ncd-surveillance/ infobase/web/InfoBasePolicyMaker/reports/ reportViewer.aspx?UN-Code= 170&rptCode=BCP&dm=18 [Accessed 7 April [2007].
23. Cornejo C, Vinueza R, Moscoso F, Calero E, Gonzalez G, Perugachi C, et al. Prevalence of arterial hypertension in the urban adult population of Ecuador: Quito, Guayaquil, and Cuenca-the PREHTAE study. CVD Prev 2000; 3:47-58.
24. Bots ML. Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 2006; 22:2181-2190.
25. Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima-media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 2002; 20:2317-2325.
26. Cuspidi C, Mancia G, Ambrosioni E, Pessina A, Trimarco B, Zanchetti A, APROS Investigators. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens 2004; 18:891-896.
27. Mancia G, Volpe R, Boros S, Ilardi M, Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens 2004; 22:51-57.
28. Strategic Priorities of the WHO Cardiovascular Disease Programme. World Health Organization Web site. http://www.who.int/ cardiovascular-diseases/ priorities/en/ [Accessed 9 February 2007].
29. Centers for Disease Control and Prevention. Achievements in public health, 1900-1999: decline in deaths from heart disease and stroke-United States, 1900-1999. MMWR Morb Mortal Wkly Rep 1999; 48:649-656. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4830a1.htm. Updated 2 May 2001 [Accessed 27 October 2007].
30. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007; 370:2044-2053.
31. Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, et al., Canadian Hypertension Education Program. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II-Therapy. Can J Cardiol 2006; 22:583-593.
32. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003; 361:717-725.
33. Mendis S, Lindholm LH, Mancia G, Whitworth J, Alderman M, Lim S, Heagerty T.World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 2007; 25:1578-1582.